Heart-Valve Replacement With Autologous Fascia Lata

Ionescu, Marian I.; Ross, D. N.

doi:10.1016/s0140-6736(69)92696-8

Cited by 92 publications

(26 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…During the same procedure, he constructed the valve during the operation by mounting the living fascia on a Dacron-covered titanium frame in the shape of a threecusp valve [29]. He began the clinical implantation of these valves in April 1969 [31,32].…”

Section: Autograft Valvesmentioning

confidence: 99%

Biological heart valves

Ciubotaru¹,

Cebotari

Tudorache

et al. 2013

Biomedizinische Technik/Biomedical Engineering

View full text Add to dashboard Cite

Cardiac valvular pathologies are often caused by rheumatic fever in young adults, atherosclerosis in elderly patients, or by congenital malformation of the heart in children, in effect affecting almost all population ages. Almost 300,000 heart valve operations are performed worldwide annually. Tissue valve prostheses have certain advantages over mechanical valves such as biocompatibility, more physiological hemodynamics, and no need for life-long systemic anticoagulation. However, the major disadvantage of biological valves is related to their durability. Nevertheless, during the last decade, the number of patients undergoing biological, rather than mechanical, valve replacement has increased from half to more than three-quarters for biological implants. Continuous improvement in valve fabrication includes development of new models and shapes, novel methods of tissue treatment, and preservation and implantation techniques. These efforts are focused not only on the improvement of morbidity and mortality of the patients but also on the improvement of their quality of life. Heart valve tissue engineering aims to provide durable, "autologous" valve prostheses. These valves demonstrate adaptive growth, which may avoid the need of repeated operations in growing patients.

show abstract

Section: Autograft Valvesmentioning

confidence: 99%

Biological heart valves

Ciubotaru¹,

Cebotari

Tudorache

et al. 2013

Biomedizinische Technik/Biomedical Engineering

View full text Add to dashboard Cite

show abstract

“…Murray in 1956 demonstrated that human aortic valves from cadavers could be used as a valve transplant in the descending thoracic aorta in patients with aortic insufficiency (Murray, 1956 (Senning, 1967;Ionescu & Ross, 1969 (Angel, 1972), substituted later by glutaraldehyde because of its ability for double-edge cross linking of collagen molecules (Woodroof, 1972), resulted in better longevity of valves. The stabilized tissue valve is sutured in specially designed frames composed of aortic ring and three commissures.…”

Section: Evolution Of Bioprosthetic Heart Valvesmentioning

confidence: 99%

Prosthetic Aortic Valves: A Surgical and Bioengineering Approach

Mavrilas¹,

Apostolakis²,

Koutsoukos³

2011

Aortic Valve Surgery

View full text Add to dashboard Cite

“…Since Senning in 1962 introduced the fascia lata in aortic valve surgery (Senning 1966), the use of autologous fascia lata in replacing the heart valves has rapidly increased (Ionescu & Ross 1969, Edwards et al 1969, Ross 1970, Dubiel et al 1973.…”

mentioning

confidence: 99%